Statement from MassBio CEO & President Kendalle Burlin O’Connell on today’s release of proposed COINS Act rules: “Today, the ...
Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), and Acesion Pharma, a Copenhagen-based biotech company developing treatments for cardiac ...
ZUG, Switzerland, Oct. 29, 2026 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet ...
New, free book offers simple but empowering information on how to care for people with cancer while also caring for yourself. Posted by National Comprehensive Cancer Network Foundation (NCCNF) Today, ...
We are pleased to share with you the 2026 MassBio Industry Snapshot. This annual report tracks the Massachusetts biopharma industry’s changes, including employment, industry investment, drug ...
Engage with the leading life sciences cluster in the world at a variety of our annual events. Explore our sponsorship opportunities today to position your company for success in 2026 - contact ...
Tufts in Translation: Predicting Glucose Responses: Building a Virtual Platform for Precision Health
Welcome back to Tufts in Translation where we spotlight faculty advancing new therapeutic approaches, targets, platforms, and delivery systems. Sessions feature early-stage research across the drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results